Pelthos Therapeutics Inc.
NYSE · Healthcare · Biological Products, (No Diagnostic Substances) · Durham, NC
PTHS chart
What traders are saying about $PTHS
Latest postsPelthos Therapeutics Inc. news
- PTHS Q2 2026 Earnings: Wider-Than-Expected Loss and Negative Surprise Pressure Shares - Consensus Forecast Report
https://www.dars.gov.et/ ·
- $PTHS stock is down 13% today. Here's what we see in our data.
Quiver Quantitative ·
- Pelthos Therapeutics (NYSEAM:PTHS) - Stock Analysis
Simply Wall Street ·
- Pelthos Therapeutics (PTHS) Stock Fair Value Falls After Analysts Cut Zelsuvmi Launch Estimates
Yahoo Finance ·
- Pelthos Therapeutics Announces Expanded Formulary Coverage for ZELSUVMI® (berdazimer) Topical Gel, 10.3%
Yahoo Finance ·
- Pelthos (PTHS) Q2 2026 Earnings Call Transcript
fool.com ·
- Pelthos Therapeutics Q2 Earnings Call Highlights
marketbeat.com ·
- Pelthos Therapeutics Inc (PTHS) (Q2 2026) Earnings Call Highlights: Revenue Surges 45% as ...
Yahoo Finance ·
- Pelthos Therapeutics Inc. Q2 2026 Earnings Call Summary
app.moby.co ·
- Pelthos Therapeutics Inc. (PTHS) Reports Q2 Loss, Lags Revenue Estimates
Yahoo Finance ·
- Pelthos Therapeutics Announces Second Quarter 2026 Financial Results
Yahoo Finance ·
- This Biotech Dealmaker — Tied To Merck, Travere — Is In A Profit-Taking Zone
Yahoo Finance ·
Pelthos Therapeutics Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $16.8M | $0 | – | – |
| Net income | -$43.3M | -$8.0M | -$7.4M | -$2.5M |
| Diluted EPS | $-23.04 | $-14.27 | $-5.78 | – |
| Total assets (year end) | $130.4M | $1.4M | $96,391 | $55,074 |
| Cash and equivalents (year end) | $18.0M | $513,000 | $100,000 | $100,000 |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Pelthos Therapeutics Inc.
- Ticker
- PTHS (NYSE)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Durham, NC
- Incorporated in
- NV
- Fiscal year end
- December 31
- SEC CIK
- 1919246
- Former names
- Channel Therapeutics Corp, Chromocell Therapeutics Corp
Frequently asked questions
What exchange is Pelthos Therapeutics Inc. listed on?
Pelthos Therapeutics Inc. trades on the NYSE under the ticker symbol PTHS.
What industry is Pelthos Therapeutics Inc. in?
Pelthos Therapeutics Inc. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is Pelthos Therapeutics Inc. headquartered?
Pelthos Therapeutics Inc.'s business address on file with the SEC is in Durham, NC.
When does Pelthos Therapeutics Inc.'s fiscal year end?
Pelthos Therapeutics Inc.'s fiscal year ends on December 31.
How much revenue did Pelthos Therapeutics Inc. report?
Pelthos Therapeutics Inc. reported $16.8M in revenue for calendar year 2025, according to its SEC filings.